1:45 pm Roundtable Discussion: Adapting Trial Methodologies to Reflect Real-World MASH Populations to Broaden Treatment Applicability
Time: 1:45 pm
day: Conf day 2
Details:
- Implementing more inclusive trial designs that incorporate diverse patient populations to ensure trial results are generalizable to a broader range of MASH patients to lead to more effective and equitable treatment strategies
- Utilizing real-world data (RWD) and patient registries to provide valuable insights into disease progression and treatment outcomes in routine clinical practice to complement traditional trial data and enhance the development of patient-centred treatment approaches
- Exploring novel endpoints beyond traditional histology to capture the full spectrum of MASH-related outcomes, including patient-reported quality of life and long-term complications to facilitate the development of therapies that address the holistic needs of MASH patients
